Published in Eur J Immunol on September 01, 1989
Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1. Proc Natl Acad Sci U S A (1992) 0.97
Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimulated mouse splenic B-cells. Nucleic Acids Res (1991) 0.82
High-dose interferon-gamma alters the distribution of B lymphocytes and macrophages in rat spleen and lymph nodes. Immunology (1993) 0.81
Forecasting agriculturally driven global environmental change. Science (2001) 16.70
An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41
Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet (1999) 3.30
Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J Immunol (1986) 3.08
Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol (2000) 2.99
Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology (1992) 2.57
Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology (1994) 2.55
17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A (1996) 2.53
Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proc Natl Acad Sci U S A (1987) 2.53
DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology (1992) 2.48
Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology (1992) 2.35
PAPYRUS 3.0: DICOM-compatible file format. Med Inform (Lond) (1995) 2.32
Measuring and modelling plant area index in beech stands. Int J Biometeorol (2004) 2.23
CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood (1990) 2.21
Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol (2001) 2.17
Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology (1987) 2.15
Targeted gene walking polymerase chain reaction. Nucleic Acids Res (1991) 2.14
Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes. Biochim Biophys Acta (1978) 2.12
Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med (2000) 2.05
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology (1992) 2.03
The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet (1998) 1.99
Impaired S-phase transit of Werner syndrome cells expressed in lymphoblastoid cell lines. Exp Cell Res (1992) 1.98
Trichodermin resistance--mutation affecting eukaryotic ribosomes. Nature (1974) 1.90
Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium, and cAMP-mediated suppression. J Immunol (1986) 1.89
An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum Genet (1997) 1.88
Cytogenetics of Werner's syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenet Cell Genet (1981) 1.85
Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1996) 1.82
Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry (1993) 1.77
CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J Immunol (1987) 1.76
Mapping of trichodermin resistance in Saccharomyces cerevisiae: a genetic locus for a component of the 60S ribsomal subunit. Genetics (1976) 1.75
Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res (1996) 1.74
Prenatal diagnosis of human genome variation. Annu Rev Genet (1979) 1.73
Werner syndrome lymphoblastoid cells are sensitive to camptothecin-induced apoptosis in S-phase. Hum Genet (1999) 1.71
Generation of a mutant form of protein synthesis initiation factor eIF-2 lacking the site of phosphorylation by eIF-2 kinases. Mol Cell Biol (1988) 1.69
Signal transduction through CD4 receptors: stimulatory vs. inhibitory activity is regulated by CD4 proximity to the CD3/T cell receptor. Eur J Immunol (1988) 1.68
Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet (1999) 1.66
Analysis of c-Ki-ras mutations in human colon carcinoma by cell sorting, polymerase chain reaction, and DNA sequencing. Cancer Res (1989) 1.63
c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology (1990) 1.59
Distinct patterns of transmembrane calcium flux and intracellular calcium mobilization after differentiation antigen cluster 2 (E rosette receptor) or 3 (T3) stimulation of human lymphocytes. J Clin Invest (1986) 1.53
Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs. Am Rev Respir Dis (1988) 1.53
Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc Natl Acad Sci U S A (1991) 1.53
Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc Natl Acad Sci U S A (1981) 1.51
Urea induces macrophage proliferation by inhibition of inducible nitric oxide synthesis. Kidney Int (1999) 1.50
Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction. Cytogenet Genome Res (2002) 1.49
Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J (2001) 1.48
Presumed trisomy for the short arm of chromosome No. 9 not due to inherited translocation. Humangenetik (1971) 1.48
Variegated translocation mosaicism in human skin fibroblast cultures. Cytogenet Cell Genet (1975) 1.45
Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16). J Immunol (1987) 1.42
Chromosome 7 short arm deletion and craniosynostosis. A 7p-syndrome. Hum Genet (1976) 1.41
Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer (2007) 1.41
17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Cancer Res (1991) 1.39
Growth characteristics of Werner syndrome cells in vitro. Adv Exp Med Biol (1985) 1.39
A developmental-specific factor binds to suppressor sites flanking the immunoglobulin heavy-chain enhancer. Genes Dev (1989) 1.39
Two classes of inhibitors of peptidyl transferase activity in eukaryotes. Nature (1974) 1.38
Stimulation of T cells through the CD3/T-cell receptor complex: role of cytoplasmic calcium, protein kinase C translocation, and phosphorylation of pp60c-src in the activation pathway. Mol Cell Biol (1987) 1.32
More on marker X chromosomes, mental retardation and macro-orchidism. N Engl J Med (1979) 1.30
Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. I. Clonal morphology and growth potential. Pediatr Res (1974) 1.29
Small structural changes of chromosome 8. Two cases with evidence for deletion. Hum Genet (1977) 1.28
The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol (2000) 1.27
Transplantation of hematopoietic stem cells obtained by a combined dye method fractionation of murine bone marrow. Blood (1990) 1.26
CD5 antibodies increase intracellular ionized calcium concentration in T cells. J Immunol (1987) 1.24
Chromosome instability and X-ray hypersensitivity in a microcephalic and growth-retarded child. Am J Med Genet (1991) 1.24
Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities. Gastroenterology (1998) 1.24
Systematic growth studies, cocultivation, and cell hybridization studies of Werner syndrome cultured skin fibroblasts. Hum Genet (1981) 1.24
[Giemsa-R-banding analysis of the trisomy 9p and report of a new case]. Humangenetik (1973) 1.23
Normalisation of sister chromatid exchange frequencies in Bloom's syndrome by euploid cell hybridisation. Nature (1979) 1.21
Retroregulation of the int gene of bacteriophage lambda: control of translation completion. Proc Natl Acad Sci U S A (1981) 1.20
Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin. J Immunol (1988) 1.19
Cytogenetic aspects of Werner syndrome. Adv Exp Med Biol (1985) 1.19
Effects of cytoskeletal disrupting agents on replication of bovine endothelium. J Cell Physiol (1981) 1.19
Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19. Proc Natl Acad Sci U S A (1988) 1.18
Significance of phenotypic and chromosomal abnormalities in X-linked mental retardation (Martin-Bell or Renpenning syndrome). Am J Med Genet (1980) 1.18
De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J Cell Physiol (1995) 1.16
Comparative heterokaryon study of cellular senescence and the serum-deprived state. Exp Cell Res (1980) 1.16
Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood (1995) 1.13
Endocarditis after nipple piercing in a patient with a bicuspid aortic valve. Ann Thorac Surg (2001) 1.12
Improved sensitivity in flow cytometric intracellular ionized calcium measurement using fluo-3/Fura Red fluorescence ratios. Cytometry (1994) 1.12
Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry (1993) 1.11
Regulation of human fibroblast growth rate by both noncycling cell fraction transition probability is shown by growth in 5-bromodeoxyuridine followed by Hoechst 33258 flow cytometry. Proc Natl Acad Sci U S A (1983) 1.11
Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet (1998) 1.11
Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology (1991) 1.11
Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol (1988) 1.10
Chronic mastopathy and breast cancer. A follow-up study. Cancer (1977) 1.09
Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am J Pathol (2000) 1.09
Trisomy of the long arm of human chromosome 1. Humangenetik (1974) 1.09
Evidence of clonal attenuation, clonal succession, and clonal expansion in mass cultures of aging Werner's syndrome skin fibroblasts. Cytogenet Cell Genet (1981) 1.08
High-quality RNA and DNA from flow cytometrically sorted human epithelial cells and tissues. Biotechniques (2002) 1.08
Inhibitors of macromolecular synthesis in yeast. Methods Cell Biol (1975) 1.08
Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas. Am J Pathol (1994) 1.08
Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis. Cytometry (1996) 1.08
Chromosome banding and DNA replication patterns in bird karyotypes. Cytogenet Cell Genet (1989) 1.07
Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy. J Clin Invest (1990) 1.07
Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma. Environ Health Perspect (1991) 1.07